INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 116 filers reported holding INSMED INC in Q2 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $7,449,000 | -99.9% | 238,700 | -59.8% | 1.82% | -18.4% |
| Q3 2016 | $8,615,239,000 | +10.8% | 593,336 | -24.8% | 2.23% | +31.4% |
| Q2 2016 | $7,778,909,000 | -44.4% | 788,936 | -28.6% | 1.70% | -39.0% |
| Q1 2016 | $14,000,325,000 | +11.9% | 1,104,998 | +60.4% | 2.78% | +99.9% |
| Q4 2015 | $12,507,292,000 | +17.1% | 689,107 | +19.8% | 1.39% | -10.5% |
| Q3 2015 | $10,685,308,000 | +94143.3% | 575,407 | +23.9% | 1.55% | -20.2% |
| Q2 2015 | $11,338,000 | +1.1% | 464,307 | -13.9% | 1.95% | -28.8% |
| Q1 2015 | $11,213,000 | +7.0% | 539,107 | -20.4% | 2.73% | -11.0% |
| Q4 2014 | $10,482,000 | +21.1% | 677,600 | +2.2% | 3.07% | +21.0% |
| Q3 2014 | $8,656,000 | -47.1% | 663,300 | -19.0% | 2.54% | -59.4% |
| Q2 2014 | $16,358,000 | – | 818,700 | – | 6.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |